Calypte's HIV test approved for addition to USAID waiver list

By Elaine Rigoli

Tampa, Fla., July 20 - Calypte Biomedical Corp. announced that its Aware BSP HIV-½ Rapid test is now approved for addition to the USAID waiver list, which permits this blood test to be used in USAID-funded projects.

USAID provides assistance in sub-Saharan Africa; Asia and the Near East; Latin America, the Caribbean, Europe and Eurasia.

The organization, which has funded almost $6 billion since the inception of its HIV/AIDS program in 1986, currently has HIV/AIDS programs in nearly 100 countries worldwide, according to a news release.

USAID is a U.S. government agency that receives overall foreign-policy guidance from the Secretary of State.

Calypte is a health care company located in Lake Oswego, Ore.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.